Business Description
Captor Therapeutics SA
ISIN : PLCPTRT00014
Compare
Compare
Traded in other countries / regions
CTX.Poland60Q.Germany IPO Date
2021-04-28Description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.04 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.69 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -98 | |||||
| 3-Year EPS without NRI Growth Rate | -57.4 | |||||
| 3-Year FCF Growth Rate | -260 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.87 | |||||
| 9-Day RSI | 49.54 | |||||
| 14-Day RSI | 50.19 | |||||
| 6-1 Month Momentum % | -6.84 | |||||
| 12-1 Month Momentum % | -48.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.32 | |||||
| Quick Ratio | 3.32 | |||||
| Cash Ratio | 2.83 | |||||
| Days Sales Outstanding | 79.28 | |||||
| Days Payable | 485.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.6 | |||||
| Shareholder Yield % | -10.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.28 | |||||
| Operating Margin % | -553.11 | |||||
| Net Margin % | -534.69 | |||||
| FCF Margin % | -418.29 | |||||
| ROE % | -102.2 | |||||
| ROA % | -76.17 | |||||
| ROIC % | -326.34 | |||||
| ROC (Joel Greenblatt) % | -802.29 | |||||
| ROCE % | -98.51 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 29.47 | |||||
| PB Ratio | 5.14 | |||||
| Price-to-Tangible-Book | 5.21 | |||||
| EV-to-EBIT | -3.99 | |||||
| EV-to-EBITDA | -4.34 | |||||
| EV-to-Revenue | 21.26 | |||||
| EV-to-FCF | -5.09 | |||||
| Price-to-Net-Current-Asset-Value | 5.83 | |||||
| Price-to-Net-Cash | 7.41 | |||||
| Earnings Yield (Greenblatt) % | -25.06 | |||||
| FCF Yield % | -15.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Captor Therapeutics SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.139 | ||
| EPS (TTM) (€) | -3.612 | ||
| Beta | 0.55 | ||
| Volatility % | 50.89 | ||
| 14-Day RSI | 50.19 | ||
| 14-Day ATR (€) | 0.475848 | ||
| 20-Day SMA (€) | 17.3525 | ||
| 12-1 Month Momentum % | -48.09 | ||
| 52-Week Range (€) | 13 - 34 | ||
| Shares Outstanding (Mil) | 4.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Captor Therapeutics SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Captor Therapeutics SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Captor Therapeutics SA Frequently Asked Questions
What is Captor Therapeutics SA(STU:60Q)'s stock price today?
The current price of STU:60Q is €17.20. The 52 week high of STU:60Q is €34.00 and 52 week low is €13.00.
When is next earnings date of Captor Therapeutics SA(STU:60Q)?
The next earnings date of Captor Therapeutics SA(STU:60Q) is 2024-05-29 Est..
Does Captor Therapeutics SA(STU:60Q) pay dividends? If so, how much?
Captor Therapeutics SA(STU:60Q) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers